Characterizing Sleep Disorders in Children & Adults With Tuberous

Status Recruiting

Clinical Trial Summary

The proposed research project is aimed at further characterization of sleep problems and evaluation of their impact in children and adults with TSC, excluding epilepsy as contributing factor. Questionnaire-based studies have shown that sleep problems occur in up to half of the children and a third of adults with tuberous sclerosis complex (TSC). However, there is only limited information on the nature of sleep problems and their impact on patients with TSC and their families.

Clinical Trial Description

Questionnaire-based studies have shown that sleep problems occur in up to half of the children and a third of adults with tuberous sclerosis complex (TSC). However, there is only limited information on the nature of sleep problems and their impact on patients with TSC and their families. It is known from a questionnaire-based study in children with TSC that they often wake early or wake frequently during the night, and that they can be more tired during the day. In some children, sleep-problems seem to be related to the presence of seizures during the night. This has been confirmed in a study on 10 children with TSC and epilepsy by a combination of polysomnography (sleep study) and electroencephalography (EEG). A questionnaire-based study in adults also revealed the association with epilepsy features, and showed influence of mental health complaints on sleep.

Sleep structure and quality will be assessed through formal sleep studies (polysomnography and actigraphy). The influence of abnormal brain activity on sleep will be mapped by simultaneous recording of brain activity by means of EEG. The impact of sleep disorders will be determined through interviews with individuals with TSC and their relatives. The investigators will also use questionnaires and diaries to supplement their findings.

Importance: It is expected that the results of this study will 1) improve our understanding of sleep problems in TSC, 2) provide additional information on the influence of TSC on sleep, 3) give a more in-depth view on the impact of sleep problems on the lives of individuals with TSC and their families, 4) increase awareness about sleep problems in TSC, and 5) contribute to a better management of sleep problems by patients and families. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03326765
Study type	Interventional
Source	Universitair Ziekenhuis Brussel
Contact	Veerle Van Mossevelde, Study coordinator
Phone	+3224763134
Email	veerle.vanmossevelde@uzbrussel.be
Status	Recruiting
Phase	N/A
Start date	September 27, 2017
Completion date	November 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05820919` - Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase	N/A
Recruiting	`NCT04786314` - The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome	N/A
Recruiting	`NCT05775731` - Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
Completed	`NCT03673397` - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression	N/A
Completed	`NCT03903263` - Sleep Disturbances in Dermatology Patients
Not yet recruiting	`NCT05950932` - Effects of Melissa Extract on Sleep Characteristics	Phase 4
Not yet recruiting	`NCT06012513` - Sleep Disorders and Quality of Life in Patients With Multiple Sclerosis
Completed	`NCT01463839` - Sleep Disorder and Oral Habits in Children	N/A
Completed	`NCT00940589` - Efficacy of Circadin® 2 mg in Patients With Mild to Moderate Alzheimer Disease Treated With AChE Inhibitor	Phase 2
Recruiting	`NCT06093633` - A Prospective Study to Evaluate the WP in Comparison to PSG in Patients Suspected of Sleep Disorders
Completed	`NCT06108115` - Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder	N/A
Completed	`NCT05511818` - Radicle Rest: A Study of Cannabinoids on Sleep and Health Outcomes	N/A
Active, not recruiting	`NCT04291014` - Light Therapy for PD - Dose Selection	N/A
Completed	`NCT04560595` - Remote Guided Caffeine Reduction	N/A
Completed	`NCT06008470` - Investigation of Respiratory Muscle Strength, Exercise Capacity, Physical Activity and Sleep Quality Level in Individuals With Covid-19 Infection
Recruiting	`NCT06129942` - Light Therapy in Parkinson's Disease	N/A
Recruiting	`NCT04318067` - Melatonin in ADHD and Sleep Problems	Phase 4
Completed	`NCT03532269` - Validation of the Sleep Assessment Algorithm in the Medical Application Nightly	N/A
Completed	`NCT03857802` - Efficiency of a Nursing Intervention in Sleep Hygiene	N/A
Recruiting	`NCT05739773` - Evaluation of the Effect of Combined Music on Sleep Disorder	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms